Conmed (CNMD) Capital Expenditures Growth (3y) (2013 - 2026)
Conmed (CNMD) Capital Expenditures Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.13 Bn | 175.83 Bn | 6.27 Bn | 1.64% |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 8.49% |
| 3 | Medtronic | 108.98 Bn | 99.76 Bn | 6.41 Bn | 8.89% |
| 4 | Boston Scientific | 68.45 Bn | 67.00 Bn | 3.61 Bn | 16.83% |
| 5 | Edwards Lifesciences | 48.01 Bn | 44.34 Bn | 1.29 Bn | 1.81% |
| 6 | GE HealthCare Technologies | 28.29 Bn | 26.01 Bn | 1.98 Bn | 7.57% |
| 7 | Dexcom | 28.25 Bn | 27.13 Bn | 750.30 Mn | 0.84% |
| 8 | Smith & Nephew | 26.91 Bn | 26.33 Bn | - | - |
| 9 | Koninklijke Philips | 25.45 Bn | 22.32 Bn | 2.07 Bn | 2.15% |
| 10 | Conmed | 1.33 Bn | 1.29 Bn | 183.45 Mn | -12.07% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -12.07% |
| Dec 31, 2025 | -3.43% |
| Sep 30, 2025 | -8.23% |
| Jun 30, 2025 | 0.10% |
| Mar 31, 2025 | 0.82% |
| Dec 31, 2024 | 8.22% |
| Sep 30, 2024 | -15.04% |
| Jun 30, 2024 | 6.24% |
| Mar 31, 2024 | -13.17% |
| Dec 31, 2023 | 15.52% |
| Sep 30, 2023 | 17.95% |
| Jun 30, 2023 | 6.47% |
| Mar 31, 2023 | 14.62% |
| Dec 31, 2022 | -2.85% |
| Sep 30, 2022 | 11.29% |
| Jun 30, 2022 | 4.64% |
| Mar 31, 2022 | -2.86% |
| Dec 31, 2021 | -12.48% |
| Sep 30, 2021 | 7.72% |
| Jun 30, 2021 | -5.14% |